Associated Papers
In silico methods for predicting functional synonymous variants.
Lin BC et al.
Genome Biology, 2023
Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations.
Parada-Márquez JF et al.
Frontiers in Pharmacology, 2023
The pharmacogenomic landscape of an Indigenous Australian population.
Samarasinghe SR et al.
Frontiers in Pharmacology, 2023
Synonymous variants that disrupt messenger RNA structure are significantly constrained in the human population.
Gaither JBS et al.
Gigascience, 2021
Novel Arg128Ala variant in Catechol-O-methyltransferase gene influence persistent pain.
Dharaniprasad G et al.
Clinical Genetics, 2020
Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortex.
Parkin GM et al.
Journal of Human Genetics, 2018
Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome.
Hronová K et al.
Physiological Research, 2016
Linking unfounded beliefs to genetic dopamine availability.
Schmack K et al.
Frontiers in Human Neuroscience, 2015
Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophrenia.
Sand PG et al.
Biological Psychiatry, 2010
Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients.
Hoenicka J et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2010
Catechol O-methyltransferase pharmacogenomics: human liver genotype-phenotype correlation and proximal promoter studies.
Zhang J et al.
Pharmacogenetics and Genomics, 2009
Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women.
Oosterhuis BE et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2008
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions.
Bakker PR et al.
Molecular Psychiatry, 2008
Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes.
Prasad P et al.
Bmc Genetics, 2008
Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms.
Srivastava V et al.
Pharmacogenetics and Genomics, 2006
Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population.
Fan JB et al.
Molecular Psychiatry, 2002
Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11.
Li T et al.
Molecular Psychiatry, 2000
Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia.
Chen CH et al.
The American Journal of Psychiatry, 1999
Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis.
van Esch AA et al.
The Netherlands Journal of Medicine, 0
Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.
Li J et al.
Mutation Research. Reviews in Mutation Research, 0